| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:MAPRE1-TM9SF4 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: MAPRE1-TM9SF4 | FusionPDB ID: 51651 | FusionGDB2.0 ID: 51651 | Hgene | Tgene | Gene symbol | MAPRE1 | TM9SF4 | Gene ID | 22919 | 9777 |
| Gene name | microtubule associated protein RP/EB family member 1 | transmembrane 9 superfamily member 4 | |
| Synonyms | EB1 | dJ836N17.2 | |
| Cytomap | 20q11.21 | 20q11.21 | |
| Type of gene | protein-coding | protein-coding | |
| Description | microtubule-associated protein RP/EB family member 1APC-binding protein EB1adenomatous polyposis coli-binding protein EB1end-binding protein 1 | transmembrane 9 superfamily member 4dinucleotide oxidase disulfide thiol exchanger 3 superfamily member 4transmembrane 9 superfamily protein member 4tumor cannibalism associated protein 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q15691 | . | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000375571, | ENST00000217315, ENST00000398022, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 10 X 7 X 7=490 | 9 X 9 X 7=567 |
| # samples | 12 | 14 | |
| ** MAII score | log2(12/490*10)=-2.02974734339405 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(14/567*10)=-2.01792190799726 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: MAPRE1 [Title/Abstract] AND TM9SF4 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | MAPRE1(31427662)-TM9SF4(30720816), # samples:3 | ||
| Anticipated loss of major functional domain due to fusion event. | MAPRE1-TM9SF4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MAPRE1-TM9SF4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MAPRE1-TM9SF4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. MAPRE1-TM9SF4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | MAPRE1 | GO:0031115 | negative regulation of microtubule polymerization | 11943150 |
| Hgene | MAPRE1 | GO:0035372 | protein localization to microtubule | 19632184|21820309 |
| Tgene | TM9SF4 | GO:0001666 | response to hypoxia | 25961573 |
| Fusion gene breakpoints across MAPRE1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across TM9SF4 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | PRAD | TCGA-J9-A8CN-01A | MAPRE1 | chr20 | 31427662 | - | TM9SF4 | chr20 | 30720816 | + |
| ChimerDB4 | PRAD | TCGA-J9-A8CN-01A | MAPRE1 | chr20 | 31427662 | + | TM9SF4 | chr20 | 30720816 | + |
| ChimerDB4 | PRAD | TCGA-J9-A8CN | MAPRE1 | chr20 | 31427662 | + | TM9SF4 | chr20 | 30720815 | + |
| ChimerDB4 | PRAD | TCGA-J9-A8CN | MAPRE1 | chr20 | 31427662 | + | TM9SF4 | chr20 | 30720816 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000375571 | MAPRE1 | chr20 | 31427662 | + | ENST00000398022 | TM9SF4 | chr20 | 30720816 | + | 4464 | 736 | 139 | 2649 | 836 |
| ENST00000375571 | MAPRE1 | chr20 | 31427662 | + | ENST00000398022 | TM9SF4 | chr20 | 30720815 | + | 4464 | 736 | 139 | 2649 | 836 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000375571 | ENST00000398022 | MAPRE1 | chr20 | 31427662 | + | TM9SF4 | chr20 | 30720816 | + | 0.002739945 | 0.9972601 |
| ENST00000375571 | ENST00000398022 | MAPRE1 | chr20 | 31427662 | + | TM9SF4 | chr20 | 30720815 | + | 0.002739945 | 0.9972601 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >51651_51651_1_MAPRE1-TM9SF4_MAPRE1_chr20_31427662_ENST00000375571_TM9SF4_chr20_30720815_ENST00000398022_length(amino acids)=836AA_BP=198 MAVNVYSTSVTSDNLSRHDMLAWINESLQLNLTKIEQLCSGAAYCQFMDMLFPGSIALKKVKFQAKLEHEYIQNFKILQAGFKRMGVDKI IPVDKLVKGKFQDNFEFVQWFKKFFDANYDGKDYDPVAARQGQETAVAPSLVAPALNKPKKPLTSSSAAPQRPISTQRTAAAPKAGPGVV RKNPGVGNGDDEAAELMQQDWLPWSLLLFSLMCETSAFYVPGVAPINFHQNDPVEIKAVKLTSSRTQLPYEYYSLPFCQPSKITYKAENL GEVLRGDRIVNTPFQVLMNSEKKCEVLCSQSNKPVTLTVEQSRLVAERITEDYYVHLIADNLPVATRLELYSNRDSDDKKKEKDVQFEHG YRLGFTDVNKIYLHNHLSFILYYHREDMEEDQEHTYRVVRFEVIPQSIRLEDLKADEKSSCTLPEGTNSSPQEIDPTKENQLYFTYSVHW EESDIKWASRWDTYLTMSDVQIHWFSIINSVVVVFFLSGILSMIIIRTLRKDIANYNKEDDIEDTMEESGWKLVHGDVFRPPQYPMILSS LLGSGIQLFCMILIVIFVAMLGMLSPSSRGALMTTACFLFMFMGVFGGFSAGRLYRTLKGHRWKKGAFCTATLYPGVVFGICFVLNCFIW GKHSSGAVPFPTMVALLCMWFGISLPLVYLGYYFGFRKQPYDNPVRTNQIPRQIPEQRWYMNRFVGILMAGILPFGAMFIELFFIFSAIW ENQFYYLFGFLFLVFIILVVSCSQISIVMVYFQLCAEDYRWWWRNFLVSGGSAFYVLVYAIFYFVNKLDIVEFIPSLLYFGYTALMVLSF -------------------------------------------------------------- >51651_51651_2_MAPRE1-TM9SF4_MAPRE1_chr20_31427662_ENST00000375571_TM9SF4_chr20_30720816_ENST00000398022_length(amino acids)=836AA_BP=198 MAVNVYSTSVTSDNLSRHDMLAWINESLQLNLTKIEQLCSGAAYCQFMDMLFPGSIALKKVKFQAKLEHEYIQNFKILQAGFKRMGVDKI IPVDKLVKGKFQDNFEFVQWFKKFFDANYDGKDYDPVAARQGQETAVAPSLVAPALNKPKKPLTSSSAAPQRPISTQRTAAAPKAGPGVV RKNPGVGNGDDEAAELMQQDWLPWSLLLFSLMCETSAFYVPGVAPINFHQNDPVEIKAVKLTSSRTQLPYEYYSLPFCQPSKITYKAENL GEVLRGDRIVNTPFQVLMNSEKKCEVLCSQSNKPVTLTVEQSRLVAERITEDYYVHLIADNLPVATRLELYSNRDSDDKKKEKDVQFEHG YRLGFTDVNKIYLHNHLSFILYYHREDMEEDQEHTYRVVRFEVIPQSIRLEDLKADEKSSCTLPEGTNSSPQEIDPTKENQLYFTYSVHW EESDIKWASRWDTYLTMSDVQIHWFSIINSVVVVFFLSGILSMIIIRTLRKDIANYNKEDDIEDTMEESGWKLVHGDVFRPPQYPMILSS LLGSGIQLFCMILIVIFVAMLGMLSPSSRGALMTTACFLFMFMGVFGGFSAGRLYRTLKGHRWKKGAFCTATLYPGVVFGICFVLNCFIW GKHSSGAVPFPTMVALLCMWFGISLPLVYLGYYFGFRKQPYDNPVRTNQIPRQIPEQRWYMNRFVGILMAGILPFGAMFIELFFIFSAIW ENQFYYLFGFLFLVFIILVVSCSQISIVMVYFQLCAEDYRWWWRNFLVSGGSAFYVLVYAIFYFVNKLDIVEFIPSLLYFGYTALMVLSF -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr20:31427662/chr20:30720816) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MAPRE1 | . |
| FUNCTION: Plus-end tracking protein (+TIP) that binds to the plus-end of microtubules and regulates the dynamics of the microtubule cytoskeleton (PubMed:12388762, PubMed:16109370, PubMed:19632184, PubMed:21646404, PubMed:23001180, PubMed:28726242, PubMed:28814570, PubMed:34608293). Promotes cytoplasmic microtubule nucleation and elongation (PubMed:12388762, PubMed:16109370, PubMed:19632184, PubMed:21646404, PubMed:28726242, PubMed:28814570). Involved in mitotic spindle positioning by stabilizing microtubules and promoting dynamic connection between astral microtubules and the cortex during mitotic chromosome segregation (PubMed:12388762, PubMed:34608293). Also acts as a regulator of minus-end microtubule organization: interacts with the complex formed by AKAP9 and PDE4DIP, leading to recruit CAMSAP2 to the Golgi apparatus, thereby tethering non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:28814570). Promotes elongation of CAMSAP2-decorated microtubule stretches on the minus-end of microtubules (PubMed:28814570). Acts as a regulator of autophagosome transport via interaction with CAMSAP2 (PubMed:28726242). May play a role in cell migration (By similarity). {ECO:0000250|UniProtKB:Q61166, ECO:0000269|PubMed:12388762, ECO:0000269|PubMed:16109370, ECO:0000269|PubMed:19632184, ECO:0000269|PubMed:21646404, ECO:0000269|PubMed:23001180, ECO:0000269|PubMed:28726242, ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:34608293}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720815 | ENST00000375571 | + | 5 | 7 | 14_116 | 199.0 | 269.0 | Domain | Calponin-homology (CH) |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720816 | ENST00000375571 | + | 5 | 7 | 14_116 | 199.0 | 269.0 | Domain | Calponin-homology (CH) |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 24_281 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 303_346 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 368_376 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 398_416 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 438_449 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 471_501 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 523_535 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 557_570 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 592_598 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 620_642 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 24_281 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 303_346 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 368_376 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 398_416 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 438_449 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 471_501 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 523_535 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 557_570 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 592_598 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 620_642 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 24_281 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 303_346 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 368_376 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 398_416 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 438_449 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 471_501 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 523_535 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 557_570 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 592_598 | 0 | 626.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 620_642 | 0 | 626.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 24_281 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 303_346 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 368_376 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 398_416 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 438_449 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 471_501 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 523_535 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 557_570 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 592_598 | 5.0 | 643.0 | Topological domain | Extracellular | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 620_642 | 5.0 | 643.0 | Topological domain | Cytoplasmic | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 282_302 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 347_367 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 377_397 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 417_437 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 450_470 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 502_522 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 536_556 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 571_591 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000217315 | 0 | 18 | 599_619 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 282_302 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 347_367 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 377_397 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 417_437 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 450_470 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 502_522 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 536_556 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 571_591 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720815 | ENST00000398022 | 0 | 18 | 599_619 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 282_302 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 347_367 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 377_397 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 417_437 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 450_470 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 502_522 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 536_556 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 571_591 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000217315 | 0 | 18 | 599_619 | 0 | 626.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 282_302 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 347_367 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 377_397 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 417_437 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 450_470 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 502_522 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 536_556 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 571_591 | 5.0 | 643.0 | Transmembrane | Helical | |
| Tgene | TM9SF4 | chr20:31427662 | chr20:30720816 | ENST00000398022 | 0 | 18 | 599_619 | 5.0 | 643.0 | Transmembrane | Helical |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720815 | ENST00000375571 | + | 5 | 7 | 185_255 | 199.0 | 269.0 | Domain | EB1 C-terminal |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720816 | ENST00000375571 | + | 5 | 7 | 185_255 | 199.0 | 269.0 | Domain | EB1 C-terminal |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720815 | ENST00000375571 | + | 5 | 7 | 208_268 | 199.0 | 269.0 | Region | Note=DCTN1-binding |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720815 | ENST00000375571 | + | 5 | 7 | 220_242 | 199.0 | 269.0 | Region | Note=APC-binding |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720816 | ENST00000375571 | + | 5 | 7 | 208_268 | 199.0 | 269.0 | Region | Note=DCTN1-binding |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720816 | ENST00000375571 | + | 5 | 7 | 220_242 | 199.0 | 269.0 | Region | Note=APC-binding |
Top |
Fusion Protein Structures |
| PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
| Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
| PDB file >>>1623_MAPRE1_31427662_TM9SF4_30720816_ranked_0.pdb | MAPRE1 | 31427662 | 31427662 | ENST00000398022 | TM9SF4 | chr20 | 30720816 | + | MAVNVYSTSVTSDNLSRHDMLAWINESLQLNLTKIEQLCSGAAYCQFMDMLFPGSIALKKVKFQAKLEHEYIQNFKILQAGFKRMGVDKI IPVDKLVKGKFQDNFEFVQWFKKFFDANYDGKDYDPVAARQGQETAVAPSLVAPALNKPKKPLTSSSAAPQRPISTQRTAAAPKAGPGVV RKNPGVGNGDDEAAELMQQDWLPWSLLLFSLMCETSAFYVPGVAPINFHQNDPVEIKAVKLTSSRTQLPYEYYSLPFCQPSKITYKAENL GEVLRGDRIVNTPFQVLMNSEKKCEVLCSQSNKPVTLTVEQSRLVAERITEDYYVHLIADNLPVATRLELYSNRDSDDKKKEKDVQFEHG YRLGFTDVNKIYLHNHLSFILYYHREDMEEDQEHTYRVVRFEVIPQSIRLEDLKADEKSSCTLPEGTNSSPQEIDPTKENQLYFTYSVHW EESDIKWASRWDTYLTMSDVQIHWFSIINSVVVVFFLSGILSMIIIRTLRKDIANYNKEDDIEDTMEESGWKLVHGDVFRPPQYPMILSS LLGSGIQLFCMILIVIFVAMLGMLSPSSRGALMTTACFLFMFMGVFGGFSAGRLYRTLKGHRWKKGAFCTATLYPGVVFGICFVLNCFIW GKHSSGAVPFPTMVALLCMWFGISLPLVYLGYYFGFRKQPYDNPVRTNQIPRQIPEQRWYMNRFVGILMAGILPFGAMFIELFFIFSAIW ENQFYYLFGFLFLVFIILVVSCSQISIVMVYFQLCAEDYRWWWRNFLVSGGSAFYVLVYAIFYFVNKLDIVEFIPSLLYFGYTALMVLSF | 836 |
Top |
pLDDT score distribution |
| pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
MAPRE1_pLDDT.png  |
TM9SF4_pLDDT.png  |
| pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
 |
Top |
Ramachandran Plot of Fusion Protein Structure |
| Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
| Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| MAPRE1 | APC, TERF1, COPS5, COPS8, CSN3, COPS7A, HDAC6, LRP1, APP, CDK2, AURKA, AURKB, TUBB, SPTAN1, FN1, VCAM1, IQCB1, ITGA4, CLIP1, TUBA1A, BAG3, LOC100158003, TUBB2A, CDK5RAP2, OLA1, SNRPD2, SNRPE, SNRPF, TBCB, YWHAZ, PAFAH1B1, PRKACA, PRKACB, STIM1, NAV1, NAV2, NAV3, TRIO, LMO2, POLE2, PSMA1, PDE4DIP, TROAP, PQBP1, MAPRE2, MAPRE1, MAPRE3, SPDYE2, CYLD, IKBKG, HSPA1A, TRAF2, ABCB1, STK11, BCL3, KAT2B, KAT5, MTUS2, KIF2C, MACF1, CLASP1, CLASP2, NUPR1, ABCE1, GAS2L1, DST, PPP1R13L, AKAP9, KIF18B, UNK, IPL1, CKAP5, SUMO3, UCHL3, NTRK1, EWSR1, SRPK2, CEP135, CEP290, LCA5, OFD1, CEP170, CEP104, DCTN1, CEP19, ACTN4, ACTN1, ADD1, ADD3, BLMH, CALM1, CALML3, CAPZA1, CD59, CLTA, CLTB, CLTC, CPM, CTNNA1, CTNNB1, DAB2, DBN1, DYNC1H1, DYNC1I2, EPS15, FLNA, FYN, GNAI2, HSP90AB1, ABLIM1, MYO1E, PCM1, PCNT, PLEC, PRKAR2A, QARS, SPTBN1, SSFA2, SVIL, TMOD1, TPM4, CLIP2, YES1, LUZP1, AXIN1, SORBS2, TAOK2, CEP350, SEC16A, WDR1, ACTR1A, PIBF1, DCTN2, SPAG5, RAB35, FGFR1OP, SYNPO, CEP162, CEP131, ERC1, COBL, LIMA1, SYBU, CEP72, MIB1, AFAP1, HYI, DYNLRB1, CCDC77, KNSTRN, NEXN, SPECC1, TBC1D31, SSX2IP, MISP, CD109, WDR90, TPRN, Prkacb, Prkar2a, U2AF2, CDH1, KLHL21, PRKAR2B, HSPA5, PSMB1, TANC2, PPP1CA, IFT52, G3BP1, SLAIN1, GTSE1, PRPF3, CASK, UBE2M, MB21D1, GPC1, ARHGEF2, KIAA1217, CD2AP, FAM83H, NDE1, CAMK2G, PKP3, JUP, CTTN, SEPT9, SLAIN2, TPT1, MAPT, SRC, BICD2, BIRC3, EP300, LRRK2, PAX6, MEOX2, KLHL12, MARCH7, ZNF653, SPDYE2B, CCSER1, C20orf202, GAS2L2, PLEKHA4, N, ORF3a, ENG, SHOC2, CDC42, BRD4, Apc2, HSPA12B, DNAJB5, DNAJC2, DNAJC6, CAMSAP2, COX8A, GOLGA1, KRT8, ARHGAP21, ARHGEF16, CAMSAP1, CAMSAP3, CBL, CCSER2, CEP170B, CKAP2, CKAP2L, DIAPH3, DIP2B, DNMBP, EIF4G2, EIF4H, EML4, HMMR, KIAA1191, KIF14, KIF1B, KIF2A, MAP1S, MAP2, MAP7, MAP7D1, MAP7D2, MAP7D3, MAP9, MAST4, NCKAP5L, PATL1, PEBP1, PLEKHA5, PPP1R13B, PRRC2A, PRRC2B, PSRC1, SH3D19, SKA3, TACC1, TACC2, TDRD3, TMEM131, TRIM36, TTBK2, UFD1L, ZC2HC1A, ALMS1, ANKRD26, ARHGAP17, C1orf198, CDKAL1, DCTN4, DLG5, DLGAP5, KIF11, LMO7, LPP, LSM14A, MAVS, MTUS1, NEK4, PABPC1, PLK1, RAPH1, SMARCE1, SND1, SYNJ2, TACC3, TANC1, VASP, VIM, WDR5, TTBK1, FCHO1, NBR1, |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| MAPRE1 |  |
| TM9SF4 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720815 | ENST00000375571 | + | 5 | 7 | 185_268 | 199.0 | 269.0 | CDK5RAP2 |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720816 | ENST00000375571 | + | 5 | 7 | 185_268 | 199.0 | 269.0 | CDK5RAP2 |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720815 | ENST00000375571 | + | 5 | 7 | 124_268 | 199.0 | 269.0 | MTUS2/TIP150 |
| Hgene | MAPRE1 | chr20:31427662 | chr20:30720816 | ENST00000375571 | + | 5 | 7 | 124_268 | 199.0 | 269.0 | MTUS2/TIP150 |
Top |
Related Drugs to MAPRE1-TM9SF4 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to MAPRE1-TM9SF4 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | MAPRE1 | C0043094 | Weight Gain | 1 | CTD_human |
| Hgene | MAPRE1 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies